By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
At RESI Europe 2025, co-organized with Biocat and held at the InterContinental Hotel in Barcelona, 44 emerging companies pitched their technologies in the Innovator’s Pitch Challenge (IPC), presenting to panels of active investors across biotech, medtech, diagnostics, and digital health. This interactive pitch event continues to be a hallmark of RESI, offering founders valuable exposure and actionable feedback from a curated group of judges representing early-stage investors and strategic partners.
With over 200 investors and 200 startups participating, RESI Europe had representation from over 35 countries spanning 5 continents. Over 3000 meetings took place, with a lot of valuable connections formed and relationships built. The IPC continues to differentiate RESI from other early-stage conferences by connecting companies directly with a coordinated investor panel that delivers both in-depth Q&A and candid guidance. Each participating company receives partnering access, exhibit space in the RESI Exhibition Hall, and the opportunity to build new relationships that could lead to partnerships and funding.
The top three scoring companies from RESI Europe were:
MOWOOT has developed Intermittent Colonic Exoperistalsis, the first purely physical, non-invasive and non-drg solution for bowel dysfunctions such as constipation. Driven by pneumatic force and individualized to each patient via real-time pressure sensors, a series of soft robotic elements externally stimulates the large intestine, resulting in healthy bowel movements. Clinically proven with over 13 scientific publications, recommended in clinical guidelines in sevral EU countries and IP protected by a series of international patents the ‘MOWOOT Bowel management System” is already on the market.
Discover MICHELANGELO, our new generation rolling walker with autonomous walking assistance. It has been designed to provide the complete safety you need to move around freely and get through your day entirely independently. Our innovative active fall prevention system enables MICHELANGELO to detect a loss of natural posture in the user’s body, to act automatically and to correct that posture so as to avoid falls thanks to real-time monitoring of the situation on the ground and the physical conditions of the user. In the end, we aim to deliver three major advantages to our users and their loved ones: 1. Enhanced Safety: Offers stability and dynamic support at all times, encouraging safer and more independent mobility. 2. Frictionless Design: No buttons or levers are required for operation, facilitating the user experience. 3. Connectivity: Allows the user’s activity to be monitored and alerts to be sent in case of emergency.
Third place: Opportunity Health
Opportunity Health is a company dedicated to the development of Opportunity, an innovative medical device designed for automatic and self-applicable de-choking. Its objective is to provide an effective solution to choking emergencies, reducing the risk of death in these cases. We are currently in the development and validation phase, with key collaborations with the University of Navarra and the Santiago de Compostela Health Research Institute (IDIS). In addition, we participate in acceleration programs such as CEIN Health and BerriUp, and we continue to advance in regulatory compliance to obtain the CE marking.
Applications are now open for the Innovator’s Pitch Challenge at RESI Boston this June. Companies interested in pitching to a panel of active investors and showcasing their technology on the exhibit floor can apply now to be considered.
Next Phase Newsletter 
Leave a comment